S-100 and HMB-45 are often used to differentiate clear cell sarcoma from epithelial tumors and synovial sarcoma, and faint keratin immunoreactivity has been observed in clear cell sarcoma (5). This evidence concerns the gene PMEL and clear cell sarcoma.